Topline fund reports 8.5% KORU Medical stake (NASDAQ: KRMD)

Rhea-AI Filing Summary

Topline Capital Partners and affiliates have disclosed an 8.5% beneficial stake in KORU Medical Systems, Inc. As of February 13, 2026, the fund beneficially owns 3,941,014 shares of KORU’s common stock.

The shares are held by Topline Capital Partners, with Topline Capital Management, LLC and Collin McBirney potentially deemed beneficial owners due to their control roles. They expressly state the position is held in the ordinary course of business and not for the purpose of changing or influencing control of KORU Medical.

Insights

Equity ownership and governance analyst

Topline Capital reports an 8.5% passive stake in KORU Medical.

Topline Capital Partners reports beneficial ownership of 3,941,014 KORU Medical common shares, representing 8.5% of the class as of February 13, 2026. This positions the fund as a sizable shareholder, though still below typical thresholds associated with control.

The filing is made on a passive ownership basis, with a certification that the securities were acquired and are held in the ordinary course of business and not to change or influence control. Topline Capital Management, LLC and Collin McBirney may be deemed beneficial owners through their roles but formally disclaim beneficial ownership beyond their pecuniary interests.

The disclosure signals the presence of a significant institutional-style holder in KORU Medical’s stock. Any future changes in percentage ownership, a shift from passive to active intent, or follow-on filings could clarify whether this stake remains purely investment-oriented or evolves into a more engaged position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 05:13 PM Learn about SEC filing dates

FAQ

What percentage of KORU Medical Systems (KRMD) shares does Topline Capital own?

Topline Capital’s fund beneficially owns 8.5% of KORU Medical’s common stock. The filing reports 3,941,014 shares as of February 13, 2026, making the fund a significant, though not controlling, shareholder based on Schedule 13G/A disclosure.

How many KORU Medical (KRMD) shares are reported in this Schedule 13G/A amendment?

The filing reports beneficial ownership of 3,941,014 shares of KORU Medical common stock. This stake, held by Topline Capital Partners, represents 8.5% of the outstanding class as of February 13, 2026, according to the ownership section of the document.

Who are the reporting persons in the KORU Medical (KRMD) Schedule 13G/A?

The reporting persons are Topline Capital Management, LLC, Topline Capital Partners, LP, and Collin McBirney. The fund holds the KORU Medical shares, while the manager entity and McBirney may be deemed beneficial owners through voting and investment authority relationships described in the filing.

Does Topline Capital seek to influence control of KORU Medical Systems (KRMD)?

The filing states the KORU Medical shares were acquired and are held in the ordinary course of business. It specifically certifies they were not acquired and are not held for the purpose of changing or influencing control of the issuer, consistent with a passive investment stance.

How is voting and dispositive power over KORU Medical (KRMD) shares allocated among the filers?

Topline Capital Management and Topline Capital Partners report sole voting and dispositive power over 3,941,014 shares. Collin McBirney reports shared voting and dispositive power over the same 3,941,014 shares, reflecting his role, while disclaiming beneficial ownership beyond his pecuniary interest.

What type of SEC filing is this for KORU Medical Systems (KRMD)?

This is an amended Schedule 13G filing reporting beneficial ownership of KORU Medical common stock. It reflects Topline Capital’s 8.5% position as of February 13, 2026, and includes the required passive-investor certification that the stake is not intended to influence control.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

KORU Medical Systems, Inc.

(Name of Issuer)

Common Stock - $0.01 par value

(Title of Class of Securities)

759910102

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 759910102

1

Names of Reporting Persons

Topline Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,941,014.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,941,014.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,941,014.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.5 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: The securities reported on this Schedule as beneficially owned by TCM (the "Securities") are held by and for the benefit of the Fund. Under the definition of "beneficial ownership" in Rule 13d-3 under the Act, it is also possible that the individual general partners, executive officers, and members of the foregoing entity might be deemed the "beneficial owners" of some or all of the Securities insofar as they may be deemed to share the power to direct the voting or disposition of such Securities. TCM, as the investment manager and general partner of the Fund, and Collin McBirney, as the member-manager of TCM, may, therefore, be deemed to beneficially own the Securities held by the Fund for the purposes of Rule 13d-3 under the Act insofar as they may be deemed to have the power to direct the voting or disposition of those Securities. Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of TCM or Mr. McBirney is, for any other purpose, the beneficial owner of any of the Securities held by the Fund, and each of TCM and Mr. McBirney expressly disclaims beneficial ownership as to the Securities held by the Fund, except to the extent of its or his pecuniary interests therein.

SCHEDULE 13G

CUSIP No. 759910102

1

Names of Reporting Persons

Topline Capital Partners, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,941,014.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,941,014.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,941,014.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.5 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: The securities reported on this Schedule as beneficially owned by TCM (the "Securities") are held by and for the benefit of the Fund. Under the definition of "beneficial ownership" in Rule 13d-3 under the Act, it is also possible that the individual general partners, executive officers, and members of the foregoing entity might be deemed the "beneficial owners" of some or all of the Securities insofar as they may be deemed to share the power to direct the voting or disposition of such Securities. TCM, as the investment manager and general partner of the Fund, and Collin McBirney, as the member-manager of TCM, may, therefore, be deemed to beneficially own the Securities held by the Fund for the purposes of Rule 13d-3 under the Act insofar as they may be deemed to have the power to direct the voting or disposition of those Securities. Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of TCM or Mr. McBirney is, for any other purpose, the beneficial owner of any of the Securities held by the Fund, and each of TCM and Mr. McBirney expressly disclaims beneficial ownership as to the Securities held by the Fund, except to the extent of its or his pecuniary interests therein.

SCHEDULE 13G

CUSIP No. 759910102

1

Names of Reporting Persons

McBirney Collin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,941,014.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,941,014.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,941,014.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.5 %

12

Type of Reporting Person (See Instructions)

HC, IN

Comment for Type of Reporting Person: The securities reported on this Schedule as beneficially owned by TCM (the "Securities") are held by and for the benefit of the Fund. Under the definition of "beneficial ownership" in Rule 13d-3 under the Act, it is also possible that the individual general partners, executive officers, and members of the foregoing entity might be deemed the "beneficial owners" of some or all of the Securities insofar as they may be deemed to share the power to direct the voting or disposition of such Securities. TCM, as the investment manager and general partner of the Fund, and Collin McBirney, as the member-manager of TCM, may, therefore, be deemed to beneficially own the Securities held by the Fund for the purposes of Rule 13d-3 under the Act insofar as they may be deemed to have the power to direct the voting or disposition of those Securities. Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of TCM or Mr. McBirney is, for any other purpose, the beneficial owner of any of the Securities held by the Fund, and each of TCM and Mr. McBirney expressly disclaims beneficial ownership as to the Securities held by the Fund, except to the extent of its or his pecuniary interests therein.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KORU Medical Systems, Inc.
(b)	Address of issuer's principal executive offices: 100 CORPORATE DRIVE, MAHWAH, NEW JERSEY 07430
Item 2.
(a)	Name of person filing: Topline Capital Management, LLC ("TCM") Topline Capital Partners, LP ("TCP" or the "Fund") Collin McBirney
(b)	Address or principal business office or, if none, residence: 544 EUCLID STREET SANTA MONICA, California 90402
(c)	Citizenship: Topline Capital Management, LLC - CALIFORNIA Topline Capital Partners, LP - DELAWARE McBirney Collin - UNITED STATES
(d)	Title of class of securities: Common Stock - $0.01 par value
(e)	CUSIP No.: 759910102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Reference is hereby made to Rows 5-9 and 11 of pages 2, 3 and 4 of this Schedule, which are incorporated by reference herein. As of February 13, 2026 the Fund beneficially owns 3,941,014 shares of the issuer's common stock.
(b)	Percent of class: 8.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Topline Capital Management, LLC - 3,941,014 Topline Capital Partners, LP - 3,941,014 McBirney Collin - 0
	(ii) Shared power to vote or to direct the vote: Topline Capital Management, LLC - 0 Topline Capital Partners, LP - 0 McBirney Collin - 3,941,014
	(iii) Sole power to dispose or to direct the disposition of: Topline Capital Management, LLC - 3,941,014 Topline Capital Partners, LP - 3,941,014 McBirney Collin - 0
	(iv) Shared power to dispose or to direct the disposition of: Topline Capital Management, LLC - 0 Topline Capital Partners, LP - 0 McBirney Collin - 3,941,014
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Topline Capital Management, LLC

Signature:	/s/ Collin McBirney
Name/Title:	By: Collin McBirney, Managing Member
Date:	02/13/2026

Topline Capital Partners, LP

Signature:	/s/ Collin McBirney
Name/Title:	By: Topline Capital Management, LLC, the General Partner By: Collin McBirney, its Managing Member
Date:	02/13/2026

McBirney Collin

Signature:	/s/ Collin McBirney
Name/Title:	Collin McBirney
Date:	02/13/2026

Exhibit Information

Exhibit A - Joint Filing Undertaking